{"organizations": [], "uuid": "8ba2a30c0bfad470333d62f793eef080c7e146cf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mabvax-receives-notice-of-sec-inve/brief-mabvax-receives-notice-of-sec-investigation-and-examination-of-certain-registration-statements-idUSFWN1PP123", "country": "US", "domain_rank": 408, "title": "BRIEF-Mabvax Receives Notice Of SEC Investigation And Examination Of Certain Registration Statements", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T15:13:00.000+02:00", "replies_count": 0, "uuid": "8ba2a30c0bfad470333d62f793eef080c7e146cf"}, "author": "", "url": "https://www.reuters.com/article/brief-mabvax-receives-notice-of-sec-inve/brief-mabvax-receives-notice-of-sec-investigation-and-examination-of-certain-registration-statements-idUSFWN1PP123", "ord_in_thread": 0, "title": "BRIEF-Mabvax Receives Notice Of SEC Investigation And Examination Of Certain Registration Statements", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "neutral"}, {"name": "registration statements reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "mabvax therapeutics holdings inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 14 PM / in 11 minutes BRIEF-Mabvax Receives Notice Of SEC Investigation And Examination Of Certain Registration Statements Reuters Staff \nJan 30 (Reuters) - Mabvax Therapeutics Holdings Inc : \n* MABVAX RECEIVES NOTICE OF SEC INVESTIGATION AND EXAMINATION OF CERTAIN REGISTRATION STATEMENTS \n* MABVAX THERAPEUTICS - RECEIVED NOTICE SEC WAS CONDUCTING INVESTIGATION RELATING TO CERTAIN OF COMPANYâ€˜S REGISTRATION STATEMENTS  ", "external_links": [], "published": "2018-01-30T15:13:00.000+02:00", "crawled": "2018-01-30T15:32:05.018+02:00", "highlightTitle": ""}